Insider Transactions by Third Rock Ventures II, L.P.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RVMDRevolution Medicines, Inc.Third Rock Ventures II, L.P.10% OwnerJun 03, 2021Sale$30.20378,11711,419,134164,996Jun 07, 2021, 06:10 PM
RVMDRevolution Medicines, Inc.Third Rock Ventures II, L.P.10% OwnerJun 04, 2021Sale$30.23164,9964,987,8290Jun 07, 2021, 06:10 PM
JNCEJounce Therapeutics, Inc.Third Rock Ventures II, L.P.10% OwnerMar 01, 2021Sale$11.751,450,00017,037,5007,750,349Mar 03, 2021, 06:00 PM
JNCEJounce Therapeutics, Inc.Third Rock Ventures II, L.P.10% OwnerNov 19, 2020Sale$7.0115,000105,0759,200,349Nov 23, 2020, 04:42 PM
JNCEJounce Therapeutics, Inc.Third Rock Ventures II, L.P.10% OwnerNov 17, 2020Sale$7.2515,000108,7739,215,349Nov 19, 2020, 05:42 PM
ALNAAllena Pharmaceuticals, Inc.Third Rock Ventures II, L.P.10% OwnerNov 06, 2017Buy$14.00215,0003,010,0002,790,964Nov 06, 2017, 04:00 PM
MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSep 25, 2017Sale$43.00201,4008,660,2007,285,104Sep 27, 2017, 04:01 PM
MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSep 26, 2017Sale$43.00400,00017,200,0006,885,104Sep 27, 2017, 04:01 PM
MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSep 08, 2017Sale$41.01201,2508,252,4997,487,404Sep 12, 2017, 04:05 PM
MYOKMyoKardia IncThird Rock Ventures II, L.P.10% OwnerSep 11, 2017Sale$44.2520,000885,08057,651Sep 12, 2017, 04:05 PM
GBTGlobal Blood Therapeutics, Inc.Third Rock Ventures II, L.P.10% OwnerMar 02, 2017Sale$25.542,045,29452,245,4766,475,191Mar 06, 2017, 07:47 PM
BPMCBlueprint Medicines CorpThird Rock Ventures II, L.P.10% OwnerFeb 07, 2017Sale$35.281,000,00035,275,0024,453,753Feb 09, 2017, 05:21 PM
GBTGlobal Blood Therapeutics, Inc.Third Rock Ventures II, L.P.10% OwnerNov 14, 2016Sale$19.362,000,00038,720,0019,475,191Nov 16, 2016, 04:12 PM
SAGESage Therapeutics, Inc.Third Rock Ventures II, L.P.10% OwnerMay 16, 2016Sale$31.254,250,000132,812,5003,892,916May 18, 2016, 04:27 PM